Gary Patou, Director at OSCIENT PHARMACEUTICALS CORP (OSCI), sold 25,000 shares at $2.29 ($57K) on 2006-02-07, disclosed to the SEC on 2006-02-09.
Scheduled sale ($57k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| XENE | SELL | 2023-12-15 | $624K | — | Filing → |
| XENE | SELL | 2023-12-15 | $1.0M | — | Filing → |
| XENE | SELL | 2022-11-28 | $276K | — | Filing → |